By Padma SundarChief Commercial Officer, Phothera For millions of Americans living with psoriasis, vitiligo, atopic dermatitis (eczema), and cutaneous T-cell lymphoma (CTCL), access to narrowband ultraviolet B (UVB) (NB-UVB) phototherapy has long been constrained by a frustrating gap between clinical evidence and insurance coverage. That gap is narrowing faster than at any point in the […]
View More
Great news for individuals living with chronic skin conditions — Cigna has officially removed restrictions on home phototherapy coverage, making this proven treatment more accessible than ever for 19.2 million members nationwide. This major policy change means patients with psoriasis, eczema, and vitiligo can now receive safe, effective narrowband UVB home phototherapy treatment without unnecessary […]
View More